BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Gorvin CM, Loh NY, Stechman MJ, Falcone S, Hannan FM, Ahmad BN, Piret SE, Reed AA, Jeyabalan J, Leo P, Marshall M, Sethi S, Bass P, Roberts I, Sanderson J, Wells S, Hough TA, Bentley L, Christie PT, Simon MM, Mallon AM, Schulz H, Cox RD, Brown MA, Huebner N, Brown SD, Thakker RV. Mice with a Brd4 Mutation Represent a New Model of Nephrocalcinosis. J Bone Miner Res 2019;34:1324-35. [PMID: 30830987 DOI: 10.1002/jbmr.3695] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
Number Citing Articles
1 Zhang S, Bai P, Lei D, Liang Y, Zhen S, Bakiasi G, Pang H, Choi SH, Wang C, Tanzi RE, Zhang C. Degradation and Inhibition of Epigenetic Regulatory Protein BRD4 Exacerbate Alzheimer’s Disease-Related Neuropathology in Cell Models. Journal of Biological Chemistry 2022. [DOI: 10.1016/j.jbc.2022.101794] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Quarrier S. The Pathophysiology of Kidney Stone Formation. Diagnosis and Management of Pediatric Nephrolithiasis 2022. [DOI: 10.1007/978-3-031-07594-0_2] [Reference Citation Analysis]
3 Hannan FM, Stevenson M, Bayliss AL, Stokes VJ, Stewart M, Kooblall KG, Gorvin CM, Codner G, Teboul L, Wells S, Thakker RV. Ap2s1 mutation causes hypercalcaemia in mice and impairs interaction between calcium-sensing receptor and adaptor protein-2. Hum Mol Genet 2021;30:880-92. [PMID: 33729479 DOI: 10.1093/hmg/ddab076] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
4 Hannan FM, Stevenson M, Bayliss AL, Stokes VJ, Stewart M, Kooblall KG, Gorvin CM, Codner G, Teboul L, Wells S, Thakker RV. Ap2s1 mutation in mice causes familial hypocalciuric hypercalcemia type 3.. [DOI: 10.1101/2020.08.10.244244] [Reference Citation Analysis]